286 Results (Page 1 of 12)
Middle East Markets Research Reports
Middle East Dental Care Market Analysis
Middle East dental care market size is at around $1.44 Bn in 2022 and is projected to reach $2.54 Bn in 2030, exhibiting a CAGR of 7.4% during the forecast period. With the majority of countries relying on crude oil for crucial contributions to the economy and ongoing political crises in the Middle East, the demand as a whole remains unaffected in fact continues to rise. Major players in UAE and Kuwait tend to expat needs like Apex Medical & Dental Clinics, Dubai Smile Dental Clinic, Al-Rashid Hospital Dental Centre, and Kuwait Dental Centre. This report is segmented by treatment type, age group, clinical setup, and demography.
Middle East Liver Cancer Therapeutics Market Analysis
This report presents a strategic analysis of the Middle East Liver Cancer Therapeutics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Middle East Liver Cancer Therapeutics Market, offering unmatched value, accuracy and expert insights.
Middle East Vitamin and Minerals Market Analysis
This report presents a strategic analysis of the Middle East Vitamin and Minerals Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Middle East Vitamin and Minerals Market, offering unmatched value, accuracy and expert insights.
Middle East Pharmaceutical Market Analysis
This report presents a strategic analysis of the Middle East Pharmaceutical Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Middle East Pharmaceutical Market, offering unmatched value, accuracy, and expert insights.
Middle East Healthcare Reimbursement Market Analysis
This report presents a strategic analysis of the Middle East Healthcare Reimbursement Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Middle East Healthcare Reimbursement Market, offering unmatched value, accuracy and expert insights.
Middle East Physiotherapy Market Analysis
The Middle East physiotherapy market size was valued at $2.12 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.85% from 2022 to 2030 and will reach $3.61 Bn in 2030. Middle East physiotherapy market is expected to grow due growing focus on preventative care, an aging population, and an increase in chronic diseases. The market is segmented by Product Type, Application Type, and End User. The major players in the Middle East physiotherapy market are Medstar Medical Equipment, Gulf Medical Equipment, Storz Medical AG, Zimmer MedizinSysteme, and others.
Middle East Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market Analysis
This report presents a strategic analysis of the Middle East Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Middle East Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market, offering unmatched value, accuracy and expert insights.
Middle East Breast Cancer Therapeutics Market Analysis
The Middle East breast cancer therapeutics market is expected to grow from $0.72 Bn in 2022 to $2.06 Bn in 2030 with a CAGR of 13.9% for the forecasted year 2022-2030. The main factors contributing to this market growth are public awareness about the treatment options and increased funding for clinical trials for breast cancer medications in the Middle East. The market is segmented by therapy, by cancer type, and by distribution channel. The main competitors in the Middle East breast cancer therapeutics market are Novartis, Mylan, and Eli Lilly.
Middle East Cancer Pain Management Market Analysis
Middle East Cancer Pain Management market is projected to grow from $260.8 Mn in 2022 to $425.18 Mn by 2030, registering a CAGR of 6.3% during the forecast period of 2022-30. The main factors driving the growth would be the rise in cancer incidence, technological advancements in pain relief, and the expansion of the healthcare industry. The market is segmented by drug type and by disease. Some of the major players include NewBridge Pharmaceuticals, Neopharma, Abbott, Pfizer, Johnson & Johnson, and Sanofi.
Middle East Patient Engagement Solutions Market Analysis
The Middle East patient engagement solutions market is projected to grow from $680.4 Mn in 2022 to $1834.58 Mn by 2030, registering a CAGR of 13.2% during the forecast period of 2022-30. The main factors driving the growth would be a rise in chronic illness incidence, rising healthcare expenses, and the demand for individualized treatment. The market is segmented by component, delivery mode, application, therapeutic area, functionality and by end-user. Some of the major players include Okadoc, Orion Health, IBM, McKesson and Wolters Kluwer.
Middle East Nutritional Supplements Market Analysis
This report presents a strategic analysis of the Middle East Nutritional Supplements Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Middle East Nutritional Supplements Market, offering unmatched value, accuracy and expert insights.
Middle East Artificial Intelligence (AI) in Healthcare Market Analysis
This report presents a strategic analysis of the Middle East Artificial Intelligence (AI) in the Healthcare Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Middle East Artificial Intelligence (AI) in the Healthcare Market, offering unmatched value, accuracy and expert insights.
Middle East Electronic Health Records Market Analysis
Middle East's Electronic Health Record (EHR) market size was valued at $1.13 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 5% from 2022 to 2030 and will reach $1.67 Bn in 2030. The Middle East EHR market will grow because healthcare professionals and patients can benefit from ambulatory care facilities through EHR. The key market players are Cerner, Allgeier, Cerner, GE Healthcare, and others.
Middle East Artificial Intelligence (AI) in Diagnostics Market Analysis
This report presents a strategic analysis of the Middle East Artificial Intelligence (AI) in the Diagnostics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Middle East Artificial Intelligence (AI) in the Diagnostics Market, offering unmatched value, accuracy, and expert insights.
Middle East Over The Counter (OTC) Pharmaceuticals Market Analysis
Middle East over-the-counter (OTC) pharmaceuticals market size was valued at $5500 Mn in 2022 and is estimated to expand at a CAGR of 6.54% from 2022 to 2030 and will reach $9129.9 Mn in 2030. OTC are non-prescription medications and are a vital component of the healthcare system, offering consumers accessible solutions for a wide range of common health issues. The market is segmented by product type and distribution channel. The key market players are Johnson and Johnson Services Inc (USA), Bayer AG (Germany), Novartis AG (Switzerland) and others.
Mexico Influenza Medications Market Analysis
Mexico influenza medications market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Due to factors such an increase in influenza cases and increasing research and development for drug development initiatives, the global market for anti-flu medications is anticipated to rise. As a result of technological developments that generate a significant pipeline of novel pharmaceuticals, this industry may experience growth. Sanofi S.A, Lupin Limited, Teva Pharmaceutical Industries Ltd, Shionogi & Co. Ltd, Macleods Pharmaceutical Ltd, Alvogen Pvt. Ltd, AstraZaneca Plc, BioCryst Pharmaceuticals Inc, F. Hoffman La Roche Ltd, Novartis AG, Vitaris AG. Are the top key players operating in this market.
Mexico Influenza Vaccine Market Analysis
Mexico influenza vaccine market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The government's increased emphasis on and support for the influenza vaccination is one of the major factors influencing the global market. Leading market players like CSL Limited, Sanofi, and GlaxoSmithKline plc are increasing their R&D expenditures in order to enhance their production capabilities and concentrate on the introduction of new vaccines, which is what is causing the industry to continue to grow. GlaxoSmithKline plc (U.K.), Sanofi (France), AstraZeneca (U.K.), CSL Limited (Australia), BIKEN Co., Ltd. (Japan), Abbott (U.S.), Sinovac (China) are the top key players operating in this market.
Mexico Inhalation Anesthesia Market Analysis
Mexico inhalation anesthesia market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market is expected to grow as a result of rising healthcare R&D spending and recent technological and scientific advancements. The market is anticipated to expand because to the rising demand for shorter hospital stays and more accessibility to healthcare services. Halocarbon Products Corporation, Hikima Pharmaceuticals PLC, Lunan Pharmaceutical Group Co. Ltd., Piramal Enterprises Limited, Jiangsu Hengrui Medicine Co. Ltd., Fresenius Kabi AG, AbbVie Inc are the top key players operating in this market.
Mexico Inhaled Nitric Oxide Market Analysis
Mexico inhaled nitric oxide market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The factors driving the growth of this market are the rising prevalence of respiratory and other associated diseases and ongoing research and development activities. The key players in this market are Mallinckrodt, Linde plc., Air Liquide, BOC Limited, Bellerophon Therapeutics, Beyond Air Inc., Halma plc, VERO Biotech, Nu-Med Plus, Getinge AB, Merck KGaA, Genosys Informatics, Geno, and Perma Pure LLC.
Mexico Interactive Wound Dressing Market Analysis
Mexico interactive wound dressing market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Technology improvements, a growth in the prevalence of chronic wounds, and an increase in surgical procedures are the main factors driving the market for interactive wound dressings. Some of the key players in this market are Johnson & Johnson Medical N.V., Integra LifeSciences Corporation, B. Braun Melsungen AG, Cardinal Health, Medline Industries, Inc., Coloplast Pty Ltd, Medtronic, Beiersdorf AG, Mölnlycke Health Care AB, etc.
Mexico Interferons Market Analysis
Mexico interferons market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. It is anticipated that the development of novel drug delivery systems and the use of interferons in combination therapy will drive the market for interferons. The key players in this market are Roche, Merck & Co., Bristol-Myers Squibb, Biogen Inc., Bayer AG, Zydus Cadila, Novartis AG, Pfizer Inc., Biosidus, Synairgen, Nanogen, Amega Biotech, Rhein Minapharm Biogenetics.
Mexico Interstitial Cystitis Drugs Market Analysis
Mexico interstitial cystitis drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rising prevalence of interstitial cystitis and public knowledge of the ailment can be attributed for the market expansion. The key players in this market are Alvogen (CVC Capital Partners), Sandoz International GmbH (Novartis AG), Sun Pharmaceutical Industries Ltd., Accord Healthcare, Avet Pharmaceuticals Inc. (Heritage Pharmaceuticals Inc.), Lannett, Viatris Inc. (Pfizer Inc.), Reckitt Benckiser Group PLC, VistaPharm, Inc, Aurobindo Pharma, Prestige Consumer Healthcare Inc.
Mexico Intravenous Solutions Market Analysis
Mexico intravenous solutions market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rise in the prevalence of malnutrition, the quicker turnaround and higher efficacy associated with intravenous solution therapy, and the rise in the geriatric population all contribute to the growth of the intravenous solutions market. The key players in this market are Fresenius Kabi AG, Pfizer, Inc., Otsuka Pharmaceutical Co., Ltd., Baxter, B. Braun Melsungen AG, Vifor Pharma Management Ltd., JW Life Science, Amanta Healthcare, ICU Medical Inc., Grifols, S.A.
Mexico Irritable Bowel Syndrome Drugs Market Analysis
Mexico irritable bowel syndrome drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Increased illness awareness, the expected timely availability of recently approved drugs, an enhanced payment system, and rising IBS prevalence are the main market drivers for IBS-D pharmaceuticals. The key players in this market are Allergan, Ironwood Pharmaceuticals, Inc., Synergy Pharmaceuticals Inc., Bausch Health, Takeda Pharmaceutical Company Limited, AstraZeneca, Sebela Pharmaceuticals Inc., Synthetic Biologics, Inc., Astellas Pharma, Inc., and Ardelyx.
Mexico Isoflavones Market Analysis
Mexico isoflavones drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market is primarily driven by three factors: the growing elderly population, technological developments in the production of isoflavones, and the rising prevalence of cancer and other chronic disorders. The major key players in this market are Cargill, BASF, DSM, Shanghai Freemen, and ADM. Other key players include Nexira Inc., Bio-gen Extracts, Sikko Industries, SK Bioland, BioMax, Avestia Pharma, NutraScience Labs, Tradichem S.L., Nutra Green Biotechnology.